Shares in Tesla were down in premarket trading as the carmaker lays out the risks from President Trump’s tariffs and his scrapping of tax credits.
Category: Customs (Tariff)
-
South Korea Jockeys for a Deal With Trump at Least as Good as Japan’s
The agreement Japan secured has added pressure on South Korea to defuse the threat of high tariffs on its exports to the United States.
-
How Trump’s Japan Deal Could Give Japanese Cars a Leg Up in the US
President Trump’s 15 percent tariff on cars from Japan has angered U.S. automakers, which make cars in Canada and Mexico subject to 25 percent tariffs.
-
Investment Fund Seals Trade Deal for Japan and Expands Trump’s Influence
President Trump will get to decide where to invest Japanese money and the United States will keep 90 percent of the profits, the White House said.
-
Trump’s Tariffs Are the Highest in a Century. But After His Threats, They Seem Like a Relief.
The president imposed tariffs on Japan, one of America’s closest allies, that would have been alarming just months ago. And markets went up.
-
Tesla Expected to Report Falling Profit as Car Sales Fall
Elon Musk has said that robotaxis are the company’s future, but most revenue still comes from cars.
-
Global Markets Rally on Japan Deal Euphoria
But more big tests loom with trade talks still continuing between the Trump administration and counterparts in China and the European Union.
-
Trump Administration Keeps 19 Percent Tariff on Indonesia in Trade Deal
The administration provided some insight into the terms that were agreed upon between Indonesia and the United States, hinting at how other vague and hastily negotiated deals may turn out.
-
Philippines’ Leader Meets With Trump to Clinch Trade Deal
President Trump announced that he had secured a deal with the country that will leave a 19 percent tariff in place, though no details were immediately available.
-
As the Dollar Slides, the Euro Is Picking Up Speed
The euro has been gaining steam as investors seek new havens during geopolitical turmoil.
-
AstraZeneca Joins Pharma Investment Push in U.S. Amid Tariff Threat
The British drug maker plans to invest $50 billion in the United States as it seeks to appease President Trump.